The treatment of stupor associated with MRI evidence of cerebrovascular disease
Objective. To describe the treatment and outcome of organic stupor associated with MRI evidence of cerebrovascular disease. Design. A case series of three patients. Setting. An urban mental health of the elderly service in southeast London. Patients. Aged 69 years, 72 years and 78 years. Two had org...
Gespeichert in:
| Veröffentlicht in: | International journal of geriatric psychiatry 1997-08, Vol.12 (8), p.791-794 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 794 |
|---|---|
| container_issue | 8 |
| container_start_page | 791 |
| container_title | International journal of geriatric psychiatry |
| container_volume | 12 |
| creator | Spear, Jon Ranger, Maya Herzberg, Joe |
| description | Objective. To describe the treatment and outcome of organic stupor associated with MRI evidence of cerebrovascular disease.
Design. A case series of three patients.
Setting. An urban mental health of the elderly service in southeast London.
Patients. Aged 69 years, 72 years and 78 years. Two had organic catatonic disorder and the third organic depressive disorder.
Interventions. Diazepam, carbamazepine, antidepressants or electroconvulsive therapy (ECT).
Main outcome measures. Resolution of symptoms and discharge from hospital.
Results. Symptoms resolved between 1 and 10 days. All patients were able to return home but relapsed over the following 12 months. One relapse occurred when a patient stopped diazepam and moclobemide.
Conclusions. It is proposed that the initial treatment of organic stupor associated with cerebrovascular disease should include a benzodiazepine or carbamazepine. If patients fail to respond then ECT should be considered. The safety of ECT is not known, when treating patients with depressive disorder associated with cerebrovascular disease. © 1997 John Wiley & Sons, Ltd. |
| doi_str_mv | 10.1002/(SICI)1099-1166(199708)12:8<791::AID-GPS606>3.0.CO;2-I |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79262015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21104460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3796-9464df42e26172bbddd98e89780b6496219fff74594be7f0be632d07b60dd6fa3</originalsourceid><addsrcrecordid>eNqFkV9v0zAUxSMEGmXwEZDygND2kHJtp3Zc0KSpgy6iULSNP29XTnyjZaRNZycb-_YkStQXkPZkyefn46NzguCEwZQB8HdHl-kiPWagdcSYlEdMawXJMePz5IPSbD4_Tc-i5bdLCfJETGG6WL_nUfokmOyfPA0mkCSzSHIBz4MX3t8AdBpLDoIDzROhuZgE66trChtHptnQtgnrIvRNu6tdaLyv89I0ZMP7srkOv1ykId2VlrY59VhOjjJX3xmft5VxoS09GU8vg2eFqTy9Gs_D4Punj1eL82i1XqaL01WUC6VlpGMZ2yLmxCVTPMustTqhRKsEMhlryZkuikLFMx1npArISApuQWUSrJWFEYfB28F35-rblnyDm9LnVFVmS3XrUWkuObDZoyBnDOJYQgf-GMDc1d47KnDnyo1xD8gA-0kQ-0mw7xf7fnGYBBnHpPuPIXaT4DAJCgRcrJFj2hm_HhO02Ybs3nbcoNPfjHrXpakKZ7Z56fcYV0rEnHXYrwG7Lyt6-CfcI9n-G2286ayjwbr0Df3ZWxv3G6USaoY_vy5xxj-fr-ILQCH-AoVXwnU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21104460</pqid></control><display><type>article</type><title>The treatment of stupor associated with MRI evidence of cerebrovascular disease</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Spear, Jon ; Ranger, Maya ; Herzberg, Joe</creator><creatorcontrib>Spear, Jon ; Ranger, Maya ; Herzberg, Joe</creatorcontrib><description>Objective. To describe the treatment and outcome of organic stupor associated with MRI evidence of cerebrovascular disease.
Design. A case series of three patients.
Setting. An urban mental health of the elderly service in southeast London.
Patients. Aged 69 years, 72 years and 78 years. Two had organic catatonic disorder and the third organic depressive disorder.
Interventions. Diazepam, carbamazepine, antidepressants or electroconvulsive therapy (ECT).
Main outcome measures. Resolution of symptoms and discharge from hospital.
Results. Symptoms resolved between 1 and 10 days. All patients were able to return home but relapsed over the following 12 months. One relapse occurred when a patient stopped diazepam and moclobemide.
Conclusions. It is proposed that the initial treatment of organic stupor associated with cerebrovascular disease should include a benzodiazepine or carbamazepine. If patients fail to respond then ECT should be considered. The safety of ECT is not known, when treating patients with depressive disorder associated with cerebrovascular disease. © 1997 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0885-6230</identifier><identifier>EISSN: 1099-1166</identifier><identifier>DOI: 10.1002/(SICI)1099-1166(199708)12:8<791::AID-GPS606>3.0.CO;2-I</identifier><identifier>PMID: 9283923</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Aged ; Anticonvulsants - therapeutic use ; Antidepressive Agents - therapeutic use ; Biological and medical sciences ; Carbamazepine - therapeutic use ; catatonia ; Catatonia - therapy ; cerebrovascular disease ; Cerebrovascular Disorders - complications ; Cerebrovascular Disorders - therapy ; Consciousness ; depressive disorder ; Depressive Disorder - therapy ; Diazepam - therapeutic use ; Electroconvulsive Therapy ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Medical sciences ; MRI ; Neurocognitive Disorders - etiology ; Neurocognitive Disorders - therapy ; Neuropharmacology ; Pharmacology. Drug treatments ; Psycholeptics: tranquillizer, neuroleptic ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Treatment Outcome ; Treatments</subject><ispartof>International journal of geriatric psychiatry, 1997-08, Vol.12 (8), p.791-794</ispartof><rights>Copyright © 1997 John Wiley & Sons, Ltd.</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291099-1166%28199708%2912%3A8%3C791%3A%3AAID-GPS606%3E3.0.CO%3B2-I$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291099-1166%28199708%2912%3A8%3C791%3A%3AAID-GPS606%3E3.0.CO%3B2-I$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2773421$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9283923$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spear, Jon</creatorcontrib><creatorcontrib>Ranger, Maya</creatorcontrib><creatorcontrib>Herzberg, Joe</creatorcontrib><title>The treatment of stupor associated with MRI evidence of cerebrovascular disease</title><title>International journal of geriatric psychiatry</title><addtitle>Int. J. Geriat. Psychiatry</addtitle><description>Objective. To describe the treatment and outcome of organic stupor associated with MRI evidence of cerebrovascular disease.
Design. A case series of three patients.
Setting. An urban mental health of the elderly service in southeast London.
Patients. Aged 69 years, 72 years and 78 years. Two had organic catatonic disorder and the third organic depressive disorder.
Interventions. Diazepam, carbamazepine, antidepressants or electroconvulsive therapy (ECT).
Main outcome measures. Resolution of symptoms and discharge from hospital.
Results. Symptoms resolved between 1 and 10 days. All patients were able to return home but relapsed over the following 12 months. One relapse occurred when a patient stopped diazepam and moclobemide.
Conclusions. It is proposed that the initial treatment of organic stupor associated with cerebrovascular disease should include a benzodiazepine or carbamazepine. If patients fail to respond then ECT should be considered. The safety of ECT is not known, when treating patients with depressive disorder associated with cerebrovascular disease. © 1997 John Wiley & Sons, Ltd.</description><subject>Aged</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Carbamazepine - therapeutic use</subject><subject>catatonia</subject><subject>Catatonia - therapy</subject><subject>cerebrovascular disease</subject><subject>Cerebrovascular Disorders - complications</subject><subject>Cerebrovascular Disorders - therapy</subject><subject>Consciousness</subject><subject>depressive disorder</subject><subject>Depressive Disorder - therapy</subject><subject>Diazepam - therapeutic use</subject><subject>Electroconvulsive Therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MRI</subject><subject>Neurocognitive Disorders - etiology</subject><subject>Neurocognitive Disorders - therapy</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psycholeptics: tranquillizer, neuroleptic</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Treatment Outcome</subject><subject>Treatments</subject><issn>0885-6230</issn><issn>1099-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV9v0zAUxSMEGmXwEZDygND2kHJtp3Zc0KSpgy6iULSNP29XTnyjZaRNZycb-_YkStQXkPZkyefn46NzguCEwZQB8HdHl-kiPWagdcSYlEdMawXJMePz5IPSbD4_Tc-i5bdLCfJETGG6WL_nUfokmOyfPA0mkCSzSHIBz4MX3t8AdBpLDoIDzROhuZgE66trChtHptnQtgnrIvRNu6tdaLyv89I0ZMP7srkOv1ykId2VlrY59VhOjjJX3xmft5VxoS09GU8vg2eFqTy9Gs_D4Punj1eL82i1XqaL01WUC6VlpGMZ2yLmxCVTPMustTqhRKsEMhlryZkuikLFMx1npArISApuQWUSrJWFEYfB28F35-rblnyDm9LnVFVmS3XrUWkuObDZoyBnDOJYQgf-GMDc1d47KnDnyo1xD8gA-0kQ-0mw7xf7fnGYBBnHpPuPIXaT4DAJCgRcrJFj2hm_HhO02Ybs3nbcoNPfjHrXpakKZ7Z56fcYV0rEnHXYrwG7Lyt6-CfcI9n-G2286ayjwbr0Df3ZWxv3G6USaoY_vy5xxj-fr-ILQCH-AoVXwnU</recordid><startdate>199708</startdate><enddate>199708</enddate><creator>Spear, Jon</creator><creator>Ranger, Maya</creator><creator>Herzberg, Joe</creator><general>John Wiley & Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>199708</creationdate><title>The treatment of stupor associated with MRI evidence of cerebrovascular disease</title><author>Spear, Jon ; Ranger, Maya ; Herzberg, Joe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3796-9464df42e26172bbddd98e89780b6496219fff74594be7f0be632d07b60dd6fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Aged</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Carbamazepine - therapeutic use</topic><topic>catatonia</topic><topic>Catatonia - therapy</topic><topic>cerebrovascular disease</topic><topic>Cerebrovascular Disorders - complications</topic><topic>Cerebrovascular Disorders - therapy</topic><topic>Consciousness</topic><topic>depressive disorder</topic><topic>Depressive Disorder - therapy</topic><topic>Diazepam - therapeutic use</topic><topic>Electroconvulsive Therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MRI</topic><topic>Neurocognitive Disorders - etiology</topic><topic>Neurocognitive Disorders - therapy</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psycholeptics: tranquillizer, neuroleptic</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Treatment Outcome</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spear, Jon</creatorcontrib><creatorcontrib>Ranger, Maya</creatorcontrib><creatorcontrib>Herzberg, Joe</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spear, Jon</au><au>Ranger, Maya</au><au>Herzberg, Joe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The treatment of stupor associated with MRI evidence of cerebrovascular disease</atitle><jtitle>International journal of geriatric psychiatry</jtitle><addtitle>Int. J. Geriat. Psychiatry</addtitle><date>1997-08</date><risdate>1997</risdate><volume>12</volume><issue>8</issue><spage>791</spage><epage>794</epage><pages>791-794</pages><issn>0885-6230</issn><eissn>1099-1166</eissn><abstract>Objective. To describe the treatment and outcome of organic stupor associated with MRI evidence of cerebrovascular disease.
Design. A case series of three patients.
Setting. An urban mental health of the elderly service in southeast London.
Patients. Aged 69 years, 72 years and 78 years. Two had organic catatonic disorder and the third organic depressive disorder.
Interventions. Diazepam, carbamazepine, antidepressants or electroconvulsive therapy (ECT).
Main outcome measures. Resolution of symptoms and discharge from hospital.
Results. Symptoms resolved between 1 and 10 days. All patients were able to return home but relapsed over the following 12 months. One relapse occurred when a patient stopped diazepam and moclobemide.
Conclusions. It is proposed that the initial treatment of organic stupor associated with cerebrovascular disease should include a benzodiazepine or carbamazepine. If patients fail to respond then ECT should be considered. The safety of ECT is not known, when treating patients with depressive disorder associated with cerebrovascular disease. © 1997 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>9283923</pmid><doi>10.1002/(SICI)1099-1166(199708)12:8<791::AID-GPS606>3.0.CO;2-I</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-6230 |
| ispartof | International journal of geriatric psychiatry, 1997-08, Vol.12 (8), p.791-794 |
| issn | 0885-6230 1099-1166 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79262015 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Aged Anticonvulsants - therapeutic use Antidepressive Agents - therapeutic use Biological and medical sciences Carbamazepine - therapeutic use catatonia Catatonia - therapy cerebrovascular disease Cerebrovascular Disorders - complications Cerebrovascular Disorders - therapy Consciousness depressive disorder Depressive Disorder - therapy Diazepam - therapeutic use Electroconvulsive Therapy Female Humans Magnetic Resonance Imaging Male Medical sciences MRI Neurocognitive Disorders - etiology Neurocognitive Disorders - therapy Neuropharmacology Pharmacology. Drug treatments Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Treatment Outcome Treatments |
| title | The treatment of stupor associated with MRI evidence of cerebrovascular disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T12%3A34%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20treatment%20of%20stupor%20associated%20with%20MRI%20evidence%20of%20cerebrovascular%20disease&rft.jtitle=International%20journal%20of%20geriatric%20psychiatry&rft.au=Spear,%20Jon&rft.date=1997-08&rft.volume=12&rft.issue=8&rft.spage=791&rft.epage=794&rft.pages=791-794&rft.issn=0885-6230&rft.eissn=1099-1166&rft_id=info:doi/10.1002/(SICI)1099-1166(199708)12:8%3C791::AID-GPS606%3E3.0.CO;2-I&rft_dat=%3Cproquest_cross%3E21104460%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21104460&rft_id=info:pmid/9283923&rfr_iscdi=true |